Kenvue Inc. (NYSE:KVUE) Receives Consensus Rating of "Hold" from Analysts

Key Points

• Analysts maintain a “Hold” consensus on Kenvue, with 12 hold ratings and three buys among 15 firms. The average 12-month price target is approximately $19.27.
• Kenvue’s latest quarterly results fell slightly short of expectations, reporting $0.31 in adjusted earnings per share versus the $0.32 consensus and $3.96 billion in revenue versus $3.97 billion expected; revenue still increased 3% year over year.
• The company offers an annualized $0.84 dividend, yielding about 4.4%, while institutional investors own 97.64% of its outstanding shares.

Shares of Kenvue Inc. (NYSE:KVUE - Get Free Report) have been assigned an average recommendation of "Hold" from the fifteen ratings firms that are currently covering the company, Marketbeat reports. Twelve equities research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $19.2727.

A number of research analysts recently commented on KVUE shares. Barclays upped their price objective on Kenvue from $18.00 to $19.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 21st. Weiss Ratings raised shares of Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a report on Monday, June 15th. Wall Street Zen lowered shares of Kenvue from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. UBS Group lowered their price target on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating for the company in a research report on Tuesday, August 11th. Finally, Zacks Research cut shares of Kenvue from a "strong-buy" rating to a "hold" rating in a report on Tuesday, July 7th.

Kenvue Stock Performance

Shares of KVUE stock opened at $19.20 on Monday. The company has a quick ratio of 0.71, a current ratio of 1.01 and a debt-to-equity ratio of 0.67. The business has a 50 day moving average of $18.95 and a two-hundred day moving average of $18.14. Kenvue has a 52 week low of $14.02 and a 52 week high of $21.84. The company has a market cap of $36.87 billion, a P/E ratio of 22.06, a PEG ratio of 1.37 and a beta of 0.47.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing analysts' consensus estimates of $0.32 by ($0.01). The company had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.97 billion. Kenvue had a return on equity of 21.22% and a net margin of 10.76%.The firm's revenue for the quarter was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.29 earnings per share. As a group, analysts anticipate that Kenvue will post 1.14 EPS for the current year.

Kenvue Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th will be given a $0.21 dividend. This is a positive change from Kenvue's previous quarterly dividend of $0.21. The ex-dividend date is Wednesday, August 12th. This represents a $0.84 annualized dividend and a yield of 4.4%. Kenvue's payout ratio is currently 96.55%.

Institutional Investors Weigh In On Kenvue

A number of hedge funds have recently made changes to their positions in the business. Arrowstreet Capital Limited Partnership acquired a new stake in Kenvue in the 2nd quarter valued at approximately $6,528,000. Jump Financial LLC boosted its position in Kenvue by 210.6% during the 2nd quarter. Jump Financial LLC now owns 54,823 shares of the company's stock worth $1,147,000 after acquiring an additional 37,170 shares during the period. AXA S.A. boosted its position in Kenvue by 21.1% during the 2nd quarter. AXA S.A. now owns 48,892 shares of the company's stock worth $1,023,000 after acquiring an additional 8,524 shares during the period. NewEdge Advisors LLC grew its stake in shares of Kenvue by 219.1% in the second quarter. NewEdge Advisors LLC now owns 97,481 shares of the company's stock worth $2,040,000 after purchasing an additional 66,930 shares in the last quarter. Finally, The Manufacturers Life Insurance Company grew its stake in shares of Kenvue by 0.6% in the second quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company's stock worth $39,217,000 after purchasing an additional 10,885 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source